| |
| |
|
| Insider
Information: |
Pops Richard F |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,303,786 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$37,782,416 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,303,786 |
|
|
| Total
Value |
$37,782,416 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Director |
2024-05-17 |
31,611 |
2005-11-23 |
0 |
Premium* |
|
|
Alkermes Plc |
ALKS |
Director and CEO, Alke... |
2024-02-08 |
1,179,675 |
2011-09-16 |
0 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
Director |
2013-05-30 |
60,000 |
|
0 |
Premium* |
|
|
Acceleron Pharma Inc |
XLRN |
Director |
2019-01-25 |
32,500 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
259 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2016-05-16 |
4 |
OE |
$3.07 |
$46,050 |
D/D |
15,000 |
31,472 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2024-05-17 |
4 |
AS |
$141.84 |
$297,860 |
D/D |
(2,100) |
31,611 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
32,500 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2018-11-12 |
4 |
AS |
$103.30 |
$425,893 |
D/D |
(4,123) |
33,636 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2024-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,199 |
33,711 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2022-05-09 |
4 |
OE |
$6.66 |
$99,900 |
D/D |
15,000 |
37,012 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2018-10-29 |
4 |
AS |
$107.13 |
$589,237 |
D/D |
(5,500) |
37,759 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2018-05-01 |
4 |
D |
$84.39 |
$105,741 |
D/D |
(1,253) |
43,259 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2018-05-01 |
4 |
OE |
$7.05 |
$105,750 |
D/D |
15,000 |
44,512 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2023-01-03 |
4 |
OE |
$12.71 |
$190,650 |
D/D |
15,000 |
44,512 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2024-02-20 |
4 |
OE |
$12.98 |
$194,700 |
D/D |
15,000 |
44,512 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2024-03-13 |
4 |
OE |
$42.76 |
$992,032 |
D/D |
23,200 |
52,712 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2013-05-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
60,000 |
|
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2018-03-06 |
4 |
OE |
$5.08 |
$190,500 |
D/D |
37,500 |
68,750 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2011-11-05 |
4 |
D |
$16.12 |
$10,107 |
D/D |
(627) |
323,727 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2011-10-03 |
4 |
AS |
$14.25 |
$1,433,432 |
D/D |
(100,000) |
324,354 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-02-01 |
4 |
AS |
$18.83 |
$1,129,992 |
D/D |
(60,000) |
340,682 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-05-17 |
4 |
D |
$16.71 |
$56,630 |
D/D |
(3,389) |
345,418 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-05-27 |
4 |
D |
$16.14 |
$31,973 |
D/D |
(1,981) |
348,173 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-07-03 |
4 |
AS |
$18.00 |
$545,446 |
D/D |
(30,299) |
348,173 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-07-05 |
4 |
AS |
$18.01 |
$142,309 |
D/D |
(7,900) |
348,173 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-07-09 |
4 |
AS |
$17.52 |
$1,082,871 |
D/D |
(61,801) |
348,173 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-09-24 |
4 |
AS |
$20.73 |
$2,072,500 |
D/D |
(100,000) |
348,173 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-10-01 |
4 |
AS |
$20.52 |
$2,051,660 |
D/D |
(100,000) |
348,173 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-10-08 |
4 |
AS |
$20.57 |
$1,195,384 |
D/D |
(58,100) |
348,173 |
0 |
- |
|
259 Records found
|
|
Page 2 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
